Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators
暂无分享,去创建一个
S. Kalko | C. Ortez | E. Gallardo | J. Colomer | J. Díaz-Manera | C. Jiménez-Mallebrera | C. Jou | A. Nascimento | S. Paco | M. A. Rodríguez | T. Casserras | M. Puigdelloses
[1] L. Kunkel,et al. Skeletal Muscle MicroRNAs: Their Diagnostic and Therapeutic Potential in Human Muscle Diseases , 2016, Journal of neuromuscular diseases.
[2] M. Girgenrath,et al. Integrin dysregulation as a possible driver of matrix remodeling in Laminin-deficient congenital muscular dystrophy (MDC1A). , 2015, Journal of neuromuscular diseases.
[3] T. Valero. Mitochondrial biogenesis: pharmacological approaches. , 2014, Current pharmaceutical design.
[4] M. Paulsson,et al. Col6a1 Null Mice as a Model to Study Skin Phenotypes in Patients with Collagen VI Related Myopathies: Expression of Classical and Novel Collagen VI Variants during Wound Healing , 2014, PloS one.
[5] K. Bushby,et al. Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy , 2013, PloS one.
[6] S. Juneja,et al. Defects in Tendon, Ligament, and Enthesis in Response to Genetic Alterations in Key Proteoglycans and Glycoproteins: A Review , 2013, Arthritis.
[7] F. Muntoni,et al. Gene Expression Profiling Identifies Molecular Pathways Associated with Collagen VI Deficiency and Provides Novel Therapeutic Targets , 2013, PloS one.
[8] A. Didangelos,et al. Extracellular Matrix Secretion by Cardiac Fibroblasts: Role of MicroRNA-29b and MicroRNA-30c , 2013, Circulation research.
[9] R. Lewis,et al. High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial. , 2013, JAMA neurology.
[10] S. Prakash,et al. Complements and the Wound Healing Cascade: An Updated Review , 2013, Plastic surgery international.
[11] C. Bönnemann,et al. COL6A3 Protein Deficiency in Mice Leads to Muscle and Tendon Defects Similar to Human Collagen VI Congenital Muscular Dystrophy* , 2013, The Journal of Biological Chemistry.
[12] R. Cohn,et al. TGF&bgr; signaling: its role in fibrosis formation and myopathies , 2012, Current opinion in rheumatology.
[13] I. Ferrer,et al. Muscle Fiber Atrophy and Regeneration Coexist in Collagen VI–Deficient Human Muscle: Role of Calpain-3 and Nuclear Factor-&kgr;B Signaling , 2012, Journal of neuropathology and experimental neurology.
[14] B. Rao,et al. Targeted Proteomics of the Secretory Pathway Reveals the Secretome of Mouse Embryonic Fibroblasts and Human Embryonic Stem Cells* , 2012, Molecular & Cellular Proteomics.
[15] M. Joglekar,et al. A Protocol for Measurement of Noncoding RNA in Human Serum , 2012, Experimental diabetes research.
[16] T. Mayadas,et al. Overview: studying integrins in vivo. , 2012, Methods in molecular biology.
[17] Y. Lim,et al. Short term supplementation of dietary antioxidants selectively regulates the inflammatory responses during early cutaneous wound healing in diabetic mice , 2011, Nutrition & metabolism.
[18] T. Stojkovic,et al. ColVI myopathies: where do we stand, where do we go? , 2011, Skeletal Muscle.
[19] C. Bönnemann. The collagen VI-related myopathies: muscle meets its matrix , 2011, Nature Reviews Neurology.
[20] D. Cho,et al. Vitamin C attenuates ERK signalling to inhibit the regulation of collagen production by LL‐37 in human dermal fibroblasts , 2010, Experimental dermatology.
[21] C. Bönnemann,et al. Congenital Muscular Dystrophies: Toward Molecular Therapeutic Interventions , 2010, Current neurology and neuroscience reports.
[22] L. DiPietro,et al. Factors Affecting Wound Healing , 2010, Journal of dental research.
[23] N. Gibran,et al. Mesenchymal stem cells induce dermal fibroblast responses to injury. , 2010, Experimental cell research.
[24] P. Friedl,et al. Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms , 2009, Cell and Tissue Research.
[25] L. Ferreira,et al. Control of the skin scarring response. , 2009, Anais da Academia Brasileira de Ciencias.
[26] L. Steinman,et al. Systems biology and its application to the understanding of neurological diseases , 2009, Annals of neurology.
[27] P. Wolters,et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. , 2008, The Journal of clinical investigation.
[28] L. Kunkel,et al. miRNAS in normal and diseased skeletal muscle , 2008, Journal of cellular and molecular medicine.
[29] M. Cooke,et al. Gene expression profiling reveals new protective roles for vitamin C in human skin cells. , 2009, Free radical biology & medicine.
[30] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[31] I. Nonaka,et al. Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease , 2007, Neurology.
[32] Susan C. Brown,et al. A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations , 2006, Neuromuscular Disorders.
[33] A. Pozzi,et al. Integrin α3β1, a Novel Receptor for α3(IV) Noncollagenous Domain and a Trans-dominant Inhibitor for Integrin αvβ3* , 2006, Journal of Biological Chemistry.
[34] K. Arimura,et al. Abnormal expression of proteoglycans in Ullrich's disease with collagen VI deficiency , 2006, Muscle & nerve.
[35] A. Pozzi,et al. Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3. , 2006, The Journal of biological chemistry.
[36] Susan C. Brown,et al. Ullrich congenital muscular dystrophy: Connective tissue abnormalities in the skin support overlap with Ehlers–Danlos syndromes , 2005, American journal of medical genetics. Part A.
[37] Rainer Breitling,et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.
[38] H. Ariga,et al. Modulation of collagen fibrillogenesis by tenascin-X and type VI collagen. , 2004, Experimental cell research.
[39] H. Ariga,et al. Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. , 2004, Experimental cell research.
[40] M. Fontès,et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease , 2004, Nature Medicine.
[41] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[42] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[43] E. Bertini,et al. Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts. , 2001, Matrix biology : journal of the International Society for Matrix Biology.
[44] E. Sahin,et al. Soluble Collagen VI Drives Serum-starved Fibroblasts through S Phase and Prevents Apoptosis via Down-regulation of Bax* , 1999, The Journal of Biological Chemistry.
[45] I. Nonaka,et al. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. , 1997, Journal of cell science.
[46] R. Glanville,et al. Type VI Collagen Anchors Endothelial Basement Membranes by Interacting with Type IV Collagen* , 1997, The Journal of Biological Chemistry.
[47] D. Schuppan,et al. Collagen VI regulates normal and transformed mesenchymal cell proliferation in vitro. , 1996, Experimental cell research.
[48] R. Timpl,et al. Binding of the NG2 Proteoglycan to Type VI Collagen and Other Extracellular Matrix Molecules* , 1996, The Journal of Biological Chemistry.
[49] R. Timpl,et al. Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI. , 1993, Experimental cell research.
[50] R. Timpl,et al. Expression of type VI collagen mRNA during wound healing. , 1993, The Journal of investigative dermatology.
[51] S. Jimenez,et al. Increased expression of type VI collagen genes in systemic sclerosis. , 1990, Arthritis and rheumatism.